The recurrence of cervical intraepithelial neoplasia in HIV-positive women: A review of the literature

International Journal of STD and AIDS

Volumn 17, Issue 8, 2006, Pages 507-511

  Tebeu, Pierre Marie ^a,b   Major, Attila L ^a   Mhawech, Paulette ^c   Rapiti, Elisabetta ^d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Provincial Hospital   (Cameroon)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d GENEVA CANCER REGISTRY   (Switzerland)

Author keywords

CIN; Excision; HIV; Recurrence

Indexed keywords

CD4 LYMPHOCYTE COUNT; COCHRANE LIBRARY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL LITERATURE; MEDLINE; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; FEMALE; HIV; HIV INFECTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL NEOPLASMS;

EID: 33747869579     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206778145703     Document Type: Review

References (36)

1. Schafer A, Friedman W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593-9
2. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992;6:173-8
3. Wright TC, Ellerbrock TV, Chiasson MA, VanDevanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with HIV: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7
4. Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404-09
5. Johnstone FD, McGoogan E, Smart GE, Brettle RP, Prescott RJ. A population-based, controlled study of the relation between infection and cervical neoplasia. Br J Obstet Gynaecol 1994;101:986-91
6. Ellerbrock T, Chiasson M, Bush BA, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7
7. Duerr A, Kieke b, Warren D, et al. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:584-90
8. Schuman P, Ohmit SE, Klein RS, et al. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003;188:128-36
9. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. Monogr Natl Cancer Inst 1998;23:43-9
10. Spinillo A, Tenti P, Zappatore G, et al. Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol Reprod Biol 1992;43:235-41
11. Adachi A, Fleming I, Burk RD, Ho GYF, Klein RS. Women with human immunodeficiency virus infection and abnormal Papanicolaou smear: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:373-7
12. Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-4
13. Petry KU, Scheffer D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-40
14. Wright TC, Koulos J, Schnoll F, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-8
15. Küppers V, v Eckardstein S, Koldovsky U, Somville T, Bender HG. Therapy and follow-up of HIV-infected women with cervical intraepithelial neoplasia. Geburtsh Frauenheilk 1994;54:612-16
16. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44
17. Maiman M, Watts H, Andersen J, Clax P, Merino M, Kendall MA. Vaginal 5-fluorouracil for high grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial. Obstet Gynecol 1999;94:954-61
18. Holcomb K, Matthews RP, Chapman JE, et al. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol 1999;74:428-31
19. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998;12:1047-56
20. Ahr A, Scharl A, Lütke K, Staszewski S, Kacer PZY, Kaufmann M. Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patients. Cancer Detect Prev 2000;24:179-85
21. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:538-43
22. Ferrero S, Arena E, De Masi E, Biasotti B, Fulcheri E, Bentivoglio G. Screening and treatment for cervical intraepithelial neoplasia (CIN) in HIV-infected women. Minerva Ginecol 2002;54:297-307
23. Tate DR, Anderson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case: control analysis. Am J Obstet Gynecol 2002;186:880-2
24. Gilles C, Manigart Y, Konopnicki D, Barlow P, Rozenberg S. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status. Gynecol Oncol 2005;96:112-18
25. Vedel P, Jakobsen H, Kryger-Baggesen N, Rank F, Bostofte E. Five-year follow up of patients with cervical intraepithelial neoplasia in the cone margins after conization. Eur J Obstet Gynecol Reprod Biol 1993;50:71-6
26. Andersen ES, Pedersen B, Nielsen K. Laser conization: the results of treatment of cervical intraepithelial neoplasia. Gynecol Oncol 1994;54:201-4
27. Gardeil F, Barry-Walsh C, Prendiville W, Clinch J, Turner MJ. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 1997;89:419-22
28. Bertelsen B, Tande T, Sandvei R, Hartveit F. Laser conization of cervical intraepithelial neoplasia grade 3: free resection margins indicative of lesion-free survival. Acta Obstet Gynecol Scand 1999;78:54-9
29. Zaitoun AM, McKee G, Coppen MJ, Thomas SM, Wilson PO. Completeness of excision and follow up cytology in patients treated with loop excision biopsy. J Clin Pathol 2000;53:191-6
30. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004;9:13-22
31. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003;15:382-8
32. Schiffman M, Cstle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127:930-4
33. Ho GY, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;15:788-92
34. Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9
35. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005;97:577-86
36. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminate and intraepithelial neoplasia: a prospective cohort study. Lancet 2002;359:108-13